‘There is and was no other gun’: Mangione team argues double jeopardy bars state murder trial
Key Points:
- Luigi Mangione, who pleaded guilty to federal stalking charges related to the killing of UnitedHealthcare CEO Brian Thompson, is seeking dismissal of his separate state murder and weapons charges, citing double jeopardy protections.
- The state trial, originally set for September, has been postponed as the court reviews whether the federal guilty plea bars the state prosecution; a decision is expected by December 10.
- Manhattan DA Alvin Bragg's office argues the state murder charges are distinct from the federal stalking charges and thus can proceed, while Mangione's lawyers contend both cases involve the same legal elements and harms.
- Mangione faces a potential life sentence federally and up to 25 years to life if convicted in state court, with legal experts noting that New York's double jeopardy law requires the cases to address distinct offenses for both prosecutions to stand.
- The case stems from Mangione's use of a 3D-printed firearm to ambush Thompson in December 2024, sparking an interstate manhunt; Mangione claims a personal grievance with the health insurance industry motivated the attack.